Xiaolan Lu
Overview
Explore the profile of Xiaolan Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao X, Xu H, Du Q, Lu X, Wang Q
Sci Rep
. 2025 Feb;
15(1):4995.
PMID: 39929938
A novel method was proposed based on gold immune chromatography assay (GICA) including the detection of antibodies targeting different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitopes to improve the...
2.
Wang G, Gao T, Liu Y, Duan J, Lu H, Jiang A, et al.
Burns Trauma
. 2025 Jan;
13:tkae066.
PMID: 39877839
Background: Non-thyroidal illness syndrome is commonly observed in critically ill patients, characterized by the inactivation of systemic thyroid hormones (TH), which aggravates metabolic dysfunction. Recent evidence indicates that enhanced TH...
3.
Shi A, Xiao S, Wang Y, He X, Dong L, Wang Q, et al.
Intern Emerg Med
. 2024 Dec;
PMID: 39661221
Background And Aims: Some studies have explored the relationship between metabolic abnormalities, elevated liver enzymes and gallstone risk, but the results have been inconsistent. The aim of this study was...
4.
Nian F, Chen Y, Xia Q, Zhu C, Wu L, Lu X
Int Immunopharmacol
. 2024 Sep;
142(Pt B):113173.
PMID: 39298816
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide, with the gut microbiota and its metabolites are important regulators of its progression. Trimethylamine N-oxide (TMAO),...
5.
Chen J, Zhou Y, Liu D, Lu X, Chen H, Huang M, et al.
J Agric Food Chem
. 2024 Mar;
72(15):8550-8568.
PMID: 38546976
Pathogenic fungi pose a significant threat to crop yields and human healthy, and the subsequent fungicide resistance has greatly aggravated these agricultural and medical challenges. Hence, the development of new...
6.
Qiao Y, Xia Q, Cao X, Xu J, Qiao Z, Wu L, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Mar;
397(9):6633-6645.
PMID: 38489081
Gastric cancer (GC) treatment regimens are still unsatisfactory. Recently, Urolithin A (UroA) has gained tremendous momentum due to its anti-tumor properties. However, the therapeutic effect and underlying mechanisms of UroA...
7.
An integrative platform for detection of RNA 2'-O-methylation reveals its broad distribution on mRNA
Tang Y, Wu Y, Wang S, Lu X, Gu X, Li Y, et al.
Cell Rep Methods
. 2024 Mar;
4(3):100721.
PMID: 38452769
Ribose 2'-O-methylation is involved in critical biological processes, but its biological functions and significance in mRNAs remain underexplored. We have developed NJU-seq, a sensitive method for unbiased 2'-O-methylation (Nm) profiling,...
8.
Xu J, Xia Q, Wu T, Shao Y, Wang Y, Jin N, et al.
Gut Microbes
. 2024 Jan;
16(1):2302065.
PMID: 38196273
Hepatic immunity is one of the driving forces for the development of nonalcoholic steatohepatitis (NASH), and targeting gut microbiota is believed to affect the hepatic immune constitution. Here, we aimed...
9.
Bai D, Cheng Y, Lu X, Namasivayam G, Sugiyama H
Front Biosci (Landmark Ed)
. 2023 Oct;
28(9):224.
PMID: 37796712
Background: Considering the remarkable heterogeneity of biological features of renal cell carcinoma (RCC), the current clinical classification that only relies on classic clinicopathological features is in urgent need of improvement....
10.
Xu J, Wu L, Deng J, Yang L, Wang Y, Tian H, et al.
BMC Endocr Disord
. 2023 Sep;
23(1):201.
PMID: 37726718
Purpose: To determine the population attributable fraction (PAF) of fatty liver disease (FLD) for type 2 diabetes mellitus (T2DM) and compare it to the PAFs of other metabolic abnormalities. Methods:...